GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Concord Biotech Ltd (BOM:543960) » Definitions » Market Cap

Concord Biotech (BOM:543960) Market Cap : ₹157,364 Mil (As of May. 14, 2024)


View and export this data going back to 2023. Start your Free Trial

What is Concord Biotech Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Concord Biotech's share price for the quarter that ended in Sep. 2023 was ₹1084.05. Concord Biotech's Shares Outstanding (EOP) for the quarter that ended in Sep. 2023 was 105 Mil. Therefore, Concord Biotech's market cap for the quarter that ended in Sep. 2023 was ₹113,409 Mil.

Concord Biotech's quarterly market cap stayed the same from Sep. 2022 (₹0 Mil) to Mar. 2023 (₹0 Mil) but then increased from Mar. 2023 (₹0 Mil) to Sep. 2023 (₹113,409 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Concord Biotech's Enterprise Value for Today is ₹155,078 Mil.


Concord Biotech Market Cap Historical Data

The historical data trend for Concord Biotech's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Concord Biotech Market Cap Chart

Concord Biotech Annual Data
Trend Mar20 Mar21 Mar22 Mar23
Market Cap
- - - -

Concord Biotech Semi-Annual Data
Mar20 Mar21 Mar22 Sep22 Mar23 Sep23
Market Cap Get a 7-Day Free Trial - - - - 113,408.97

Competitive Comparison of Concord Biotech's Market Cap

For the Biotechnology subindustry, Concord Biotech's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Concord Biotech's Market Cap Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Concord Biotech's Market Cap distribution charts can be found below:

* The bar in red indicates where Concord Biotech's Market Cap falls into.



Concord Biotech Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Concord Biotech's Market Cap for the fiscal year that ended in Mar. 2023 is calculated as

Market Cap (A: Mar. 2023 )=Share Price (A: Mar. 2023 )*Shares Outstanding (EOP) (A: Mar. 2023 )
=₹0*104.616
=₹0

Concord Biotech's Market Cap for the quarter that ended in Sep. 2023 is calculated as

Market Cap (Q: Sep. 2023 )=Share Price (Q: Sep. 2023 )*Shares Outstanding (EOP) (Q: Sep. 2023 )
=₹1084.05*104.616
=₹113,409

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Concord Biotech  (BOM:543960) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


Concord Biotech Market Cap Related Terms

Thank you for viewing the detailed overview of Concord Biotech's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.


Concord Biotech (BOM:543960) Business Description

Traded in Other Exchanges
Address
Iscon Cross Road, S.G. Highway, 16th floor, B-Wing, Mondeal Heights, Ahmedabad, GJ, IND, 380015
Concord Biotech Ltd is a Research & development-driven biopharma Company that manufactures Active Pharmaceutical Ingredients (API) through fermentation & semi-synthetic process and finished formulations.

Concord Biotech (BOM:543960) Headlines

No Headlines